Corporate

QPS Announces Ard Vink as Department Head, Clinical Operations in Austria

(Newark, DE; December 11, 2014) – QPS Holdings, LLC, a leading full-service contract research organization, has named Ard Vink, PhD as new Department Head Clinical Operations in Austria. Vink became active with QPS on November 15th, leveraging his vast experience working in all phases of drug development to oversee European clinical research activities coordinated through the QPS affiliate in Graz, Austria.

“It is my pleasure to announce the hiring of Ard Vink as our new department head of clinical operations, based in Austria,” said Ben Chien, PhD, QPS President and CEO. “Beyond his top notch scientific credentials, having worked as a lead on both the CRO and sponsor sides of clinical research, Ard will provide a uniquely balanced perspective on how we may best serve our clients.”

Vink’s noteworthy academic background in oncology and immunology includes a PhD in skin cancer from the Leiden University and a post-doctoral fellowship at the MD Anderson Cancer Institute in Houston, TX. For the past 9 years, he worked for Amgen biopharmaceuticals, first in the Netherlands and later in Vienna, leading Central and Eastern European clinical operations teams to conduct numerous clinical trials with excellence and efficiency. Before that, Vink worked with clinical research organizations TNO, Farma Research and Kendle.

QPS brought Vink on board to further strengthen its clinical research capabilities in Europe. The new department head has relocated to the Graz area and will work out of the Grambach office.

Download
back
top
20 years in pharma R&D navigation